Bee pollen samples from China and Spain exhibited in vitro antioxidant, anti‐inflammatory, and digestive enzyme inhibitory activities due to their composition, suggesting their potential as a nutraceutical or functional ingredient to help counteract oxidative stress, chronic inflammation, and metabolic disorders.
Adriana Maite Fernández‐Fernández +9 more
wiley +1 more source
Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg
Courtney Crayne, Randy Q. Cron
doaj
nCD64 index as a new early predictive biomarker for macrophage activation syndrome in adult-onset still's disease. [PDF]
Wu T +10 more
europepmc +1 more source
Abstract Cardiovascular diseases (CVDs) remain the leading cause of global mortality, necessitating effective preventive and adjunct therapeutic strategies beyond conventional pharmacological interventions. Although previous reviews have focused on individual nutrients or dietary patterns, this review provides a mechanism‐based, integrative perspective
Sridevi Shanmugam +7 more
wiley +1 more source
Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h. [PDF]
Munárriz D +23 more
europepmc +1 more source
Punicic acid (PA) was enriched and purified from PSO by molecular distillation with significant anti‐inflammatory activity to RAW264.7 cells, as well as to zebrafish. Anti‐inflammatory mechanism involved regulating NF‐κB and MAPK signaling pathways. ABSTRACT Punicic acid (PA) is the main fatty acid in pomegranate seeds, which shows multiple biological ...
Mengqi Zhang +8 more
wiley +1 more source
Hemophagocytic Lymphohistiocytosis (HLH) or Macrophage Activation Syndrome (MAS)? A Lethal Case of Malignancy-Associated Hemophagocytic Lymphohistiocytosis in a Patient With Concurrent Autoimmune Disease. [PDF]
Cargill M +6 more
europepmc +1 more source
Macrophage Activation Syndrome in Adult-Onset Still's Disease: Challenges in Early Detection and Management. [PDF]
Regmi A +4 more
europepmc +1 more source
No association of HLA-DRB1*15:01 and HLA-DRB1*11 in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome and other secondary hemophagocytic lymphohistiocytoses. [PDF]
Hinze CH +6 more
europepmc +1 more source
Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report. [PDF]
Faggioli P +10 more
europepmc +1 more source

